Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
i
048530
vs
K
KOSPI 200
Over the past 12 months, iNtRON Biotechnology Inc has underperformed KOSPI 200, delivering a return of -26% compared to KOSPI 200's +119% growth.
Stocks Performance
048530 vs KOSPI 200
Performance Gap
048530 vs KOSPI 200
Performance By Year
048530 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
iNtRON Biotechnology Inc
Glance View
iNtRON Biotechnology Inc. develops and sells molecular diagnostics products and biotech tools. Its business centers on kits, reagents, and related products used to detect pathogens and analyze biological samples, along with some animal-health and research-related offerings. In plain terms, it helps labs and clinics identify disease-causing organisms and perform tests faster and more reliably. Its main customers are laboratories, hospitals, research institutions, and distributors that buy testing consumables and diagnostic products. The company makes money by selling these products to end users and through distribution channels, with recurring demand coming from items that need to be replaced and replenished over time. Because its products sit close to the testing step, it plays a useful role in the diagnostics value chain rather than trying to be a broad drug maker. What makes this business model different is that it depends on specialized know-how in detection chemistry, assay design, and life-science manufacturing. That gives iNtRON a focused position in a niche of the biotech industry where customers care about test accuracy, ease of use, and product consistency. It is not selling a single blockbuster medicine; it is supplying the tools that other healthcare and research users rely on every day.